Phanes Therapeutics
Latest round
- Series B
Last raised
- May 2021
Total raised
- $40M
Investors
- 5
About Phanes Therapeutics
Established in 2016 and based in San Diego, US, Phanes Therapeutics, Inc. is biotech company that engages in research and developing innovative drugs in immuno-oncology and eye disease.Wang Minghan, was a former vice president of Johnson & Johnson. The company mainly operates two technology platforms, PACbody and ATACCbody. The PACbody platform can constructs native IgG-like bispecific antibodies. The ATACCbody platform can build bispecific antibodies with modulated activities. It aim to use immuno-oncology molecules to treat tumor diseases.
Who invested in Phanes Therapeutics
5 investors across 2 rounds
See all investors in Phanes Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Phanes Therapeutics
Who invested in Phanes Therapeutics?
Phanes Therapeutics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Phanes Therapeutics raised?
Phanes Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Phanes Therapeutics last raise money?
Phanes Therapeutics's most recent round on record is a Series B, in May 2021.
What does Phanes Therapeutics do?
Established in 2016 and based in San Diego, US, Phanes Therapeutics, Inc.
Where is Phanes Therapeutics headquartered?
Phanes Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Phanes Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Phanes Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Phanes Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.